From: Bacterial infections in Lilongwe, Malawi: aetiology and antibiotic resistance
 | Gram positive organisms | S. aureus | S. pneumoniae | |
---|---|---|---|---|
Antibiotic | Resistant n/N (%) | Resistant + Intermediate n/N (%) | Resistant n/N (%) | Resistant n/N (%) |
Chloramphenicol | 59/171 (34.5) | 77/171 (45.0) | 30/95 (31.6) | 17/51 (33) |
Clindamycin | 19/188 (10.1) | 72/188 (38.3) | 14/143 (9.8)†| 3/30 (10.0) †|
Erythromycin | 62/220 (28.2) | 112/220 (50.9) | 51/122 (41.8) | 1/67 (1.5) |
Gentamicin | 60/183 (32.8) | 77/183 (42.1) | 28/141 (19.9) | 23/27 (85.2) |
Oxacillin | 70/230 (30.4) | 84/230 (36.5) | 46/147 (31.3) | 11/59 (18.6)* |
Tetracycline | 135/222 (60.8) | 150/222 (67.6) | 81/129 (62.8) | 32/63 (50.8) |
Tmp-Sxt | 149/199 (74.9) | 158/199 (79.4) | 88/127 (69.3) | 42/47 (89.4) |
 | Gram negative organisms | Salmonella spp . | ||
 | Resistant n/N (%) | Resistant + Intermediate n/N (%) | Resistant n/N (%) | Resistant + Intermediate n/N (%) |
Chloramphenicol | 49/69 (71.0) | 52/69 (75.4) | 12/17 (70.1) | 12/17 (70.6) |
Gentamicin | 27/80 (33.8) | 31/80 (38.8) | 0/19 (0.0) | 2/19 (10.5) |
Tmp-Sxt | 53/65 (81.5) | 54/65 (83.1) | 12/15 (80.0) | 12/15 (80.0) |
Ampicillin | 65/84 (77.4) | 69/84 (82.1) | 18/21 (85.7) | 18/21 (85.7) |
Ceftriaxone | 16/85 (18.8) | 29/85 (34.1) | 0/20 (5.0) | 1/20 (5.0) |
Ciprofloxacin | 9/75 (12.0) | 20/75 (26.7) | 0/22 (0.0) | 0/22 (0.0) |
Nalidixic acid | 26/79 (32.9) | 44/79 (55.7) | 0/20 (0.0) | 9/20 (45.0) |